In vitro studies by peripheral blood mononuclear cells infected with M. Tuberculosis found an apparently reduced production of IFN-γ and IL-12 with neutralizing anti-OPN monoclonal antibody [45], suggesting circulating OPN may serving as a reliable indicator of improvement during the early stage of anti-tuberculous treatment regimens. This evidence concerns the gene SPP1 and tuberculosis.